Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbon Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN110183427A offers efficient synthesis for pharmaceutical intermediates. Reduces toxic reagents and improves total yield to 42.2% for scalable production.
Patent CN108440473A reveals a high-yield synthesis for Marangucycline B intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN108610386A reveals a scalable synthesis for hexuronic acid glycosides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with our advanced catalytic process.